pifithrin has been researched along with 2,5-bis(5-hydroxymethyl-2-thienyl)furan in 1 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 1 (100.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Choi, JY; Ko, JH; Koch, WM; Moon, SJ; Roh, JL; Ryu, CH | 1 |
1 other study(ies) available for pifithrin and 2,5-bis(5-hydroxymethyl-2-thienyl)furan
Article | Year |
---|---|
The p53-reactivating small-molecule RITA enhances cisplatin-induced cytotoxicity and apoptosis in head and neck cancer.
Topics: Animals; Antineoplastic Combined Chemotherapy Protocols; Apoptosis; bcl-2-Associated X Protein; Benzothiazoles; Caspase 3; Cell Cycle Checkpoints; Cell Line, Tumor; Cisplatin; Cyclin-Dependent Kinase Inhibitor p21; Drug Synergism; Furans; G2 Phase; Head and Neck Neoplasms; Humans; Male; Mice; Mice, Inbred BALB C; Mice, Nude; Proto-Oncogene Proteins c-mdm2; Toluene; Tumor Suppressor Protein p53; Xenograft Model Antitumor Assays | 2012 |